C Arruabarrena1, F J Muñoz-Negrete, C Márquez, G Rebolleda. 1. Servicio de Oftalmología, Sección de Glaucoma, Hospital Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, España. carruabarrena@eresmas.com
Abstract
PURPOSE: To assess the efficacy and safety of nonpenetrating deep sclerectomy in uveitic glaucoma. METHODS: In this observational retrospective trial, 6 eyes with inflammatory glaucoma underwent a nonpenetrating deep sclerectomy and a reticulated hyaluronic acid implant. The minimal follow-up period was 12 months. RESULTS: At 12 months, the complete success rate (defined as an IOP higher than 5 and lower than 21 mmHg without medication) was 66.67% and the qualified success rate was 100%. The mean postoperative IOP at 12 months was 16.67 mmHg (SD: 3.26), and the mean IOP reduction was 23.00 mmHg (SD:13.75) (p= 0.027). The mean number of antiglaucoma medications required was reduced from 2.67 (SD: 0.52) before surgery to 0.50 (SD: 0.84) one year after surgery (p= 0.038). No change on visual acuity was observed. Complications included one case of hyphema and one case of bleb encapsulation. CONCLUSIONS: Nonpenetrating deep sclerectomy in this preliminary study, deep sclerectomy was efficacious and had few postoperative complications, so it can be an alternative in the management of uveitic glaucoma.
PURPOSE: To assess the efficacy and safety of nonpenetrating deep sclerectomy in uveitic glaucoma. METHODS: In this observational retrospective trial, 6 eyes with inflammatory glaucoma underwent a nonpenetrating deep sclerectomy and a reticulated hyaluronic acid implant. The minimal follow-up period was 12 months. RESULTS: At 12 months, the complete success rate (defined as an IOP higher than 5 and lower than 21 mmHg without medication) was 66.67% and the qualified success rate was 100%. The mean postoperative IOP at 12 months was 16.67 mmHg (SD: 3.26), and the mean IOP reduction was 23.00 mmHg (SD:13.75) (p= 0.027). The mean number of antiglaucoma medications required was reduced from 2.67 (SD: 0.52) before surgery to 0.50 (SD: 0.84) one year after surgery (p= 0.038). No change on visual acuity was observed. Complications included one case of hyphema and one case of bleb encapsulation. CONCLUSIONS: Nonpenetrating deep sclerectomy in this preliminary study, deep sclerectomy was efficacious and had few postoperative complications, so it can be an alternative in the management of uveitic glaucoma.
Authors: Nestor Ventura-Abreu; Joana Mendes-Pereira; Marta Pazos; Ma Jesús Muniesa-Royo; Andrea Gonzalez-Ventosa; Barbara Romero-Nuñez; Elena Milla Journal: J Curr Glaucoma Pract Date: 2021 May-Aug
Authors: Francisco J Muñoz-Negrete; Javier Moreno-Montañés; Paula Hernández-Martínez; Gema Rebolleda Journal: Biomed Res Int Date: 2015-10-19 Impact factor: 3.411